Ian Goodwin is a Director in the Viral Gene Therapy Global Program Design team at FUJIFILM Diosynth Biotechnologies (FDB), based in College Station, Texas. He has been at FDB for five years, having also served as Associate Principal Scientist Group Leader in the Process Development group. Ian is currently responsible for providing technical and project scope development support to prospective clients engaged in CDMO selection for viral and non-viral cell & gene therapy products. Ian’s previous experience includes nine years working on the process development and manufacturing of adeno-associated virus (AAV) and lentivirus vectors (LV) in academic, start-up, and CDMO environments. Ian holds a Master’s Degree in Microbiology and Immunology from Drexel University College of Medicine and a B.Sc in Microbiology from The University of Pittsburgh.